[HTML] springer.comFull View

[HTML][HTML] Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma

Y Qian, Y Gong, Z Fan, G Luo, Q Huang… - Journal of hematology & …, 2020 - Springer
Pancreatic ductal adenocarcinoma (PDAC) is a malignancy characterized by a poor
prognosis and high mortality rate. Genetic mutations and altered molecular pathways serve …
被引用次数：225 相关文章
[PDF] d-nb.info

[PDF][PDF] Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma

Y Qian, Y Gong, Z Fan, G Luo, Q Huang, S Deng… - 2020 - d-nb.info
Pancreatic ductal adenocarcinoma (PDAC) is a malignancy characterized by a poor
prognosis and high mortality rate. Genetic mutations and altered molecular pathways serve …

Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma.

Y Qian, Y Gong, Z Fan, G Luo, Q Huang… - Journal of Hematology …, 2020 - go.gale.com
Pancreatic ductal adenocarcinoma (PDAC) is a malignancy characterized by a poor
prognosis and high mortality rate. Genetic mutations and altered molecular pathways serve …

Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma

Y Qian, Y Gong, Z Fan, G Luo, Q Huang… - Journal of Hematology …, 2020 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Pancreatic ductal adenocarcinoma (PDAC) is
a malignancy characterized by a poor prognosis and high mortality rate. Genetic mutations …

Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma.

Y Qian, Y Gong, Z Fan, G Luo, Q Huang… - … of Hematology & …, 2020 - europepmc.org
Pancreatic ductal adenocarcinoma (PDAC) is a malignancy characterized by a poor
prognosis and high mortality rate. Genetic mutations and altered molecular pathways serve …

Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma

Y Qian, Y Gong, Z Fan, G Luo… - … of hematology & …, 2020 - pubmed.ncbi.nlm.nih.gov
Pancreatic ductal adenocarcinoma (PDAC) is a malignancy characterized by a poor
prognosis and high mortality rate. Genetic mutations and altered molecular pathways serve …
[PDF] archive.org

[PDF][PDF] Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma

Y Qian, Y Gong, Z Fan, G Luo, Q Huang, S Deng… - 2020 - scholar.archive.org
Pancreatic ductal adenocarcinoma (PDAC) is a malignancy characterized by a poor
prognosis and high mortality rate. Genetic mutations and altered molecular pathways serve …
[HTML] nih.gov

[HTML][HTML] Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma

Y Qian, Y Gong, Z Fan, G Luo, Q Huang… - … of Hematology & …, 2020 - ncbi.nlm.nih.gov
Pancreatic ductal adenocarcinoma (PDAC) is a malignancy characterized by a poor
prognosis and high mortality rate. Genetic mutations and altered molecular pathways serve …

Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma.

Y Qian, Y Gong, Z Fan, G Luo… - … of Hematology & …, 2020 - search.ebscohost.com
Pancreatic ductal adenocarcinoma (PDAC) is a malignancy characterized by a poor
prognosis and high mortality rate. Genetic mutations and altered molecular pathways serve …
[HTML] biomedcentral.com

[HTML][HTML] Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma

Y Qian, Y Gong, Z Fan, G Luo… - … of Hematology & …, 2020 - jhoonline.biomedcentral.com
Pancreatic ductal adenocarcinoma (PDAC) is a malignancy characterized by a poor
prognosis and high mortality rate. Genetic mutations and altered molecular pathways serve …